Label: GOOD SENSE LEVOCETIRIZINE- levocetirizine dihydrochloride tablet, film coated

  • NDC Code(s): 0113-0241-00, 0113-0241-01, 0113-0241-27
  • Packager: L. Perrigo Company
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated July 13, 2026

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient (in each tablet)

    Levocetirizine dihydrochloride 5 mg

  • Purpose

    Antihistamine

  • Uses

    temporarily relieves these symptoms due to hay fever or other respiratory allergies:

    •
    runny nose
    •
    itchy, watery eyes
    •
    sneezing
    •
    itching of the nose or throat
  • Warnings

    Do not use

    •
    if you have kidney disease
    •
    if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing cetirizine

    Ask a doctor before use if you have

    •
    ever had trouble urinating or emptying your bladder

    When using this product

    •
    drowsiness may occur
    •
    avoid alcoholic drinks
    •
    alcohol, sedatives, and tranquilizers may increase drowsiness
    •
    be careful when driving a motor vehicle or operating machinery

    Stop use and ask a doctor if

    •
    you have trouble urinating or emptying your bladder
    •
    an allergic reaction to this product occurs. Seek medical help right away.

    If pregnant or breast-feeding:

    •
    if breast-feeding: not recommended
    •
    if pregnant: ask a health professional before use

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

  • Directions

    adults 65 years of age and older
    •
    ask a doctor

    adults and children 12-64 years of age
    •
    take 1 tablet (5 mg) once daily in the evening
    •
    do not take more than 1 tablet (5 mg) in 24 hours
    •
    ½ tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms

    children 6-11 years of age
    •
    take ½ tablet (2.5 mg) once daily in the evening
    •
    do not take more than ½ tablet (2.5 mg) in 24 hours

    children under 6 years of age
    •
    do not use

    consumers with kidney disease
    •
    do not use
  • Other information

    •
    store between 20° and 25°C (68° and 77°F)
    •
    do not use if printed foil under cap is broken or missing
  • Inactive ingredients

    hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide

  • Questions or comments?

    1-800-719-9260

  • Package/Label Principal Display Panel

    GOODSENSE®

    Allergy

    Original Prescription Strength

    Levocetirizine Dihydrochloride Tablets, 5 mg

    Antihistamine

    Actual Size

    24 Hour Relief of:

    • Sneezing

    • Runny Nose

    • Itchy Nose or Throat

    • Itchy, Watery Eyes

    Compare to active ingredient of XYZAL® Allergy 24HR

    35 Tablets

    goodsense-levocetirizine-carton-image.jpg
  • INGREDIENTS AND APPEARANCE
    GOOD SENSE LEVOCETIRIZINE 
    levocetirizine dihydrochloride tablet, film coated
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0113-0241
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LEVOCETIRIZINE DIHYDROCHLORIDE (UNII: SOD6A38AGA) (LEVOCETIRIZINE - UNII:6U5EA9RT2O) LEVOCETIRIZINE DIHYDROCHLORIDE5 mg
    Inactive Ingredients
    Ingredient NameStrength
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    Product Characteristics
    ColorWHITEScore2 pieces
    ShapeOVALSize8mm
    FlavorImprint Code L9CZ;5
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0113-0241-011 in 1 CARTON09/11/2020
    135 in 1 BOTTLE; Type 0: Not a Combination Product
    2NDC:0113-0241-271 in 1 CARTON06/18/2026
    2NDC:0113-0241-0080 in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21198309/11/2020
    Labeler - L. Perrigo Company (006013346)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!